The relation between prostate-specific antigen and whole-body bone scan result
1 Nuclear medicine technology department, Inaya Medical Colleges, Riyadh, Riyadh, Saud Arabia.
2 Radiological Sciences department, Inaya Medical Colleges, Riyadh, Riyadh, Saudi Arabia.
3 Nuclear Medicine Technology department, Inaya Medical Colleges Riyadh, Riyadh, Saudi Arabia.
4 Radiation Safety officer, Prevention Field Company for Consultations, Riyadh, Riyadh, Saudi Arabia.
Research Article
International Journal of Scientific Research Updates, 2023, 06(01), 118–125.
Article DOI: 10.53430/ijsru.2023.6.1.0064
Publication history:
Received on 30 July 2023; revised on 12 September 2023; accepted on 14 September 2023
Abstract:
The nuclear medicine bone scan is a versatile tool because of its high sensitivity for tumors, infection, and trauma, as well as its ability to image the entire skeleton at a reasonable cost, In this study we evaluate the correlation between the prostate-specific antigen number and bone scan result in patients that were diagnosed with prostate cancer. Method: Tc99m-MDP whole body bone scan was analyzed for 100 patients whose ages range between 66-92 years with a mean of 77 years, PSA level ranges from 0-100ng/ml,50% of bone scan result was normal and 50% of patient results had bone metastases. Results: The results show that there is no correlation between the PSA level of the patient and the bone scan result, and there is no correlation between the patient's ages and PSA levels. Conclusions: There was no correlation between PSA level and whole-body scan results in this study.
Keywords:
Nuclear medicine; Prostate-specific antigen; Whole body bone scan; Prostate cancer.
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0